Axios @axios
The Veterans Health Administration said that it intends to pay for a $26,500-a-year experimental Alzheimer's drug that the Centers for Medicare and Medicaid Services has to date declined to cover. https://t.co/iFU8dRJGmF — PolitiTweet.org